With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
UAE President, Italy PM discuss regional developments
UAE expresses solidarity over Kenya road collision
Five UAE convoys deliver 617 tonnes of aid to Gaza
H.H. Sheikh Hamdan attends unveiling of UAE asteroid mission probe
RTA organising inaugural Dubai conference on sustainable transport and mobility
Anwar Gargash reiterates UAE position on three islands
UAE human rights body calls for safeguards in climate technology
UAE and Kazakhstan expand cooperation in transport, energy and AI
